THE WHAT? A U.S. judge has approved Johnson & Johnson’s plans to use the bankruptcy system to resolve its multibillion-litigation that claim its talc products cause cancer, according to Reuters.
THE DETAILS In October 2021, J&J put the claims into the newly created entity LTL Management LLC, which then filed for bankruptcy days later.
The strategy is known as the Texas two-step – this allows companies to split valuable assets from liabilities through a so-called divisive merger, according to Reuters.
Plantiffs have argued that the move is an abuse of Chapter 11 system, with attorney Jon Ruckdeschel stating that the ruling would be appealed.
THE WHY? The decision to use the bankruptcy strategy will allow J&J to avoid fighting more than 38,000 individual lawsuits.
Ruckdeschel said of the move, “The bankruptcy code was never intended to be abused in this way by massively profitable corporations as a means to delay or prevent cancer victims from having their day in court.”
While some plaintiffs have stated it could open the floodgates for other companies facing mass litigation, Judge Kaplan said, “There is nothing to fear in the migration of tort litigation out of the tort system and into the bankruptcy system.”
He continued that ‘maybe the gates indeed should be opened.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
